Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

NCT05854303 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2025-10-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Conditions

  • Opioid-Induced Esophageal Dysfunction

Interventions

BEHAVIORAL

Opioid cessation

opioid cessation will occur during pain rehabilitative program over approximately 3 weeks

OTHER

No opioid cessation

Subjects will not stop taking opioids

Sponsors & Collaborators

Principal Investigators

  • Diana Snyder, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-18
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05854303 on ClinicalTrials.gov